The current and future role of biomarkers in type 2 cytokine-mediated asthma management-Reference-Cited by-同舟云学术

The current and future role of biomarkers in type 2 cytokine-mediated asthma management

Published:2017-01-30 Issue:2 Volume:47 Page:148-160
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Pavord I. D.¹,Afzalnia S.²,Menzies-Gow A.³,Heaney L. G.⁴

Affiliation:

1. Respiratory Medicine Unit; Nuffield Department of Medicine; University of Oxford; Oxford UK

2. Roche Products Ltd; Welwyn Garden City Hertfordshire UK

3. Lung Division; Royal Brompton Hospital; London UK

4. Centre for Experimental Medicine; School of Medicine; Dentistry and Biomedical Sciences; Queen's University Belfast; Belfast UK

Funder

Roche

MedImmune

Novartis

Hoffmann-La Roche/Genentech Inc.

AstraZeneca

GlaxoSmithKline

Respivert

Merck Sharp and Dohme

Nycomed

Boehringer Ingelheim

Vectura

Chiesi Farmaceutici

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.12881/fullpdf

Reference124 articles.

1. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention 2016a http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/

2. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention; Online Appendix 2016b http://ginasthma.org/2016-online-appendix-global-strategy-for-asthma-management-and-prevention/

3. Asthma UK Asthma facts and statistics 2016 https://www.asthma.org.uk/about/media/facts-and-statistics/

4. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens;Holtzman;J Clin Invest,2012

5. Type-2 innate lymphoid cells in human allergic disease;Barlow;Curr Opin Allergy Clin Immunol,2014

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 severe asthma: pathophysiology and treatment with biologics;Expert Review of Respiratory Medicine;2024-07-02

2. Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement;Expert Opinion on Pharmacotherapy;2024-05-23

3. Pulmonology: What You May Have Missed in 2023;Annals of Internal Medicine;2024-05

4. Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease;Thorax;2024-02-19

5. Association of serum YKL-40 and DPP4 with T2-high asthma in Chinese adults;Medicine;2024-02-09